Double FOYA Winners | How we’re delivering award-winning pharmaceutical facilities with Design to Value

That means more cost and more time which, ultimately, is going to affect the patient who is at the end of that supply chain.

However, there are plans for an application to Innovate UK and their Smart Grant funding programme.Of course, digitising the entire planning process is an enormous goal, and for efficiency’s sake, the process will have to begin with a single use case.

Double FOYA Winners | How we’re delivering award-winning pharmaceutical facilities with Design to Value

Ricketts feels the best and most informative starting point is building safety, highlighting MHCLG’s external wall system survey as a good example of data collection and collation..The MHCLG project asked local authorities to research and report back on the materials present in the external walls of all buildings above 18 metres within a particular borough.Although it sounds like a straightforward task, in reality it presented some unexpectedly complex questions and issues to surmount.

Double FOYA Winners | How we’re delivering award-winning pharmaceutical facilities with Design to Value

What is a building?Is it the postal address?

Double FOYA Winners | How we’re delivering award-winning pharmaceutical facilities with Design to Value

The single address with three blocks in it?.

Next came the question of how best to approach obtaining the information.Engaging with stakeholders to build an initial model of a solution.

We start out by discussing with our client in more detail what the fundamental problem is that they are facing.We need to understand who is affected by it and its solution.

This allows us to identify the stakeholders and what they value.We then determine with our client – and key stakeholders – what the high level aspects are of a solution that would solve this problem.